# Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism

> **NCT01421407** · NA · WITHDRAWN · sponsor: **Theraclion**

## Conditions studied

- Secondary Hyperparathyroidism
- End Stage Renal Disease
- Parathyroid Hyperplasia

## Interventions

- **DEVICE:** Ultrasonic ablation device

## Key facts

- **NCT ID:** NCT01421407
- **Lead sponsor:** Theraclion
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-08
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01421407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01421407, "Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01421407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*